CMC & Process Development

Chemistry, Manufacturing, and Controls (CMC) is the most technically demanding component of botanical drug development — and the section of a botanical IND submission most frequently flagged by the FDA. Our services span the full manufacturing lifecycle, from laboratory-scale process development through cGMP clinical trial material production, commercial scale-up, and quality release — all designed to meet FDA botanical drug CMC requirements. The service is fulfilled by our botanical API manufacturing partner at www.BotanicalAPI.com.

Botanical GMP Process Development & Technology Transfer

Translating a botanical drug substance process from laboratory bench to GMP manufacturing scale requires specialized expertise that accounts for the unique physicochemical complexity of botanical APIs. ABDC provides end-to-end botanical drug CMC process development and technology transfer services:

Botanical Drug Scale-Up: Seamless, science-driven transition of botanical drug substance and drug product manufacturing processes from laboratory scale to full cGMP production — with particular expertise in identifying and resolving scale-up failure points unique to botanical matrices.
Technology Transfer Management: Expert management of technology transfer for both botanical drug substances and finished drug products, ensuring manufacturing knowledge, analytical methods, and quality standards are faithfully transferred to GMP manufacturing sites.
Botanical Drug Product Formulation Optimization: Refinement and optimization of botanical drug product formulations to ensure GMP manufacturability, dosing accuracy, and clinical performance — a critical CMC milestone for botanical IND submissions.

GMP Production of Botanical Clinical Trial Materials

Clinical Trial Materials (CTM) Manufacturing: GMP manufacture of high-quality botanical drug clinical trial materials for Phase 1, 2, and 3 clinical studies, produced in compliance with FDA and ICH GMP requirements.
Commercial-Scale Botanical Manufacturing: Scalable cGMP production capabilities for approved botanical drug products, supporting the transition from clinical development to commercial supply.

Botanical Drug Quality Release & Stability

Batch Release Testing: Comprehensive analytical testing of finished botanical drug batches against all approved specifications, ensuring every lot meets FDA botanical drug quality standards before release.
Certificate of Analysis (CoA): Issuance of detailed, FDA-compliant Certificates of Analysis documenting every Critical Quality Attribute (CQA) for each released batch of botanical drug substance or finished product.
ICH-Compliant Botanical Stability Programs: Design and execution of stability studies conducted in strict accordance with ICH Q1A through Q1E guidelines, establishing shelf-life specifications for botanical drug substances and finished drug products.

Botanical Drug OEM Manufacturing

ABDC's botanical drug OEM manufacturing capabilities combine FDA-certified GMP infrastructure, proprietary extraction technology, and rigorous quality systems to deliver pharmaceutical-grade botanical drug substances and finished products for global markets.

FDA-Certified GMP Manufacturing Facilities: cGMP-certified botanical drug manufacturing facilities in Allentown, PA, USA, ensuring strict adherence to FDA GMP standards and U.S. regulatory requirements for botanical drug production.
Proprietary Botanical Extraction Technology: Over 30 international patents and intellectual property rights protecting the unique botanical extraction and processing technologies used in our manufacturing operations — a foundation of consistent, reproducible botanical drug substance quality.
Full-Spectrum Botanical Extraction: Cutting-edge extraction methodologies designed to retain the complete chemical profile of botanical raw materials, preserving the multifactorial therapeutic activity that defines botanical drug efficacy.
Global Regulatory Compliance: Manufacturing operations designed to meet international GMP standards across multiple regulatory jurisdictions, providing botanical drug sponsors with confidence in global market access.

Water Based Botanical Extraction

Water-based extraction is a cornerstone of botanical drug substance manufacturing, preserving the full-spectrum chemical complexity of botanical APIs while maintaining alignment with traditional medicine preparation methods. ABDC's water-based botanical extraction process incorporates rigorous quality controls at every stage:

GACP-Certified Botanical Sourcing: Raw herbal materials are exclusively sourced from contracted, GACP-certified farms, ensuring full traceability, authenticated botanical identity, and quality consistency from the point of harvest — a foundational FDA requirement for botanical drug CMC documentation.
Pharmacopoeial Compliance: All botanical processing adheres strictly to applicable pharmacopoeial standards, ensuring botanical drug substance quality is grounded in established, internationally recognized reference standards.
Toxicity Reduction & Botanical Safety Processing: Botanical raw materials undergo rigorous cleaning and traditional processing procedures — including steaming, fermenting, germinating, freezing, and stir-frying with liquid adjuvants — to minimize toxicity and enhance the safety profile of the botanical drug substance prior to extraction.

Filtration & Concentration

Precise filtration and concentration of botanical extracts are critical steps in botanical drug substance manufacturing, directly impacting chemical composition, purity, and batch-to-batch consistency:

Low-Temperature Botanical Filtration: Botanical decoctions are filtered at controlled temperatures between 40–60°C to minimize thermal degradation of heat-sensitive bioactive constituents — preserving the full therapeutic chemical profile of the botanical drug substance.
ISO Class 6 Cryoconcentration: Concentration processes are conducted within an ISO Class 6 controlled clean environment, ensuring sterility, preventing microbial contamination, and maintaining botanical drug substance integrity.
Integrated Quality Monitoring: A continuous quality monitoring system ensures batch-to-batch consistency and product integrity throughout the filtration and concentration stages of botanical drug substance manufacturing.

Spray Drying

Converting botanical liquid extracts into stable, standardized botanical drug substance powders requires precise spray drying technology optimized for the thermal sensitivity of botanical APIs:

Optimized Spray Drying Technology: Brief, controlled hot-air exposure rapidly converts botanical extracts into dry powder form, minimizing thermal degradation and maximizing retention of heat-sensitive active ingredients — critical for maintaining the therapeutic potency of botanical drug substances.
Standardized Physical Properties: Strict process control maintains consistency in all critical physical parameters — including particle morphology, color, texture, and moisture content — across all production batches.
Precision Moisture Control: Exact regulation of residual water content ensures long-term botanical drug substance stability and batch-to-batch uniformity, supporting ICH stability compliance.

Essential Oil Recovery

Volatile essential oils are frequently lost during conventional botanical extraction processes, compromising the full therapeutic chemical profile of the botanical drug substance. ABDC's proprietary essential oil restoration technology preserves the complete botanical API:

Essential Oil Recovery During Extraction: Capture and preservation of volatile botanical essential oils during the water-based extraction process, preventing the loss of bioactive volatile components that contribute to the botanical drug's multifactorial therapeutic activity.
Beta-Cyclodextrin Inclusion Encapsulation: Application of Beta-Cyclodextrin inclusion complex technology to stabilize volatile botanical oils and convert them into stable, solid forms compatible with pharmaceutical manufacturing processes.
Full Chemical Profile Restoration: Systematic re-integration of recovered, solidified essential oils into the final botanical drug substance powder, restoring the complete chemical fingerprint of the original botanical material and supporting FDA "Totality of Evidence" characterization requirements.

Granulation

Precise granulation of botanical drug substances is essential for achieving the flowability, solubility, and dosing accuracy required for pharmaceutical-grade botanical drug products:

Precision Extrusion: Controlled transformation of botanical drug substance crystalline material into uniform thin-slice granules, ensuring consistent particle density across production batches.
Controlled Particle Sizing: Multi-stage crushing and particle sizing processes engineered to achieve exact, predetermined particle dimensions that meet botanical drug product specifications.
Granule Standardization: Strict adherence to particle size distribution specifications ensures optimal flowability, dissolution performance, and dosing accuracy for botanical drug finished products.

Quality Assurance & Analytical Testing

ABDC's botanical drug quality assurance laboratory is equipped with state-of-the-art analytical instrumentation and operates under rigorous GMP quality standards:

Advanced Analytical Instrumentation: Full suite of pharmaceutical-grade analytical equipment — including CAMAG REPROSTAR, HPLC, GC, and ICP-AES — providing the analytical precision required for botanical drug substance and finished product quality testing.
Botanical Safety & Purity Screening: Comprehensive safety testing covering bacterial contamination, heavy metals, pesticide residues, and mycotoxins — all critical quality attributes for botanical drug IND and NDA submissions.
Active Ingredient Quantification: HPLC and GC-based quantification of botanical drug substance active markers, confirming potency and concentration consistency across production lots.
Botanical Fingerprinting by HPTLC: Advanced High-Performance Thin-Layer Chromatography (HPTLC) generates a specific botanical fingerprint profile for each botanical drug substance batch, providing authenticated botanical identity and supporting FDA botanical characterization requirements.
Full FDA Regulatory Compliance: All botanical drug substance and finished product testing meets U.S. FDA GMP requirements, with comprehensive Certificates of Analysis (CoA) covering botanical authentication, chemical purity, and microbiological safety.

Inspection & Storage

Precision Automated Packaging: Advanced automation for final botanical drug product packaging, maximizing efficiency and minimizing contamination risk through reduced human contact.
Trained Quality Personnel Visual Inspection: A final, critical layer of quality assurance through rigorous visual inspection by trained GMP personnel, ensuring every unit meets release specifications before distribution.
Climate-Controlled Botanical Drug Storage: All finished botanical drug products are stored in strictly climate-controlled environments to prevent chemical degradation, preserve therapeutic potency, and protect product integrity throughout the distribution chain.
Secure Chain of Custody: End-to-end product security and monitoring from the manufacturing line through shipping, ensuring full traceability and integrity for every botanical drug shipment.

ABDC's botanical drug CMC capabilities — from GACP-certified raw material sourcing through GMP manufacturing, quality release, and climate-controlled distribution — provide botanical drug sponsors with a fully integrated, FDA-compliant manufacturing solution.

Google Sites

Report abuse